Search Results
Found 9 results for "denmark" across articles, medicines, trials, companies and the glossary
Pharmaceutical
Ireland's Eight-Year Citizenship Rule: A Talent-Retention Problem for Pharma, Biotech and MedTech
Ireland built a life-science powerhouse by being the easiest place in Europe for global talent to land and stay. The proposed move from five to eight years for citizenship changes the terms on which the sector's skilled workforce agreed to come here. This analysis looks at what it means for engineers and scientists on Critical Skills permits, for the companies that depend on them, and what a fairer Bill would look like.
Industry
Ireland's Eight-Year Citizenship Rule: Why It Risks Punishing the Nurses, Carers and Pharma Professionals the Country Cannot Do Without
The Government wants to raise the residency requirement for Irish citizenship from five years to eight, with language and civics tests on top. This analysis looks at who actually carries the weight of that change: the internationally trained nurses, care assistants and pharmaceutical professionals who keep Irish hospitals, nursing homes and manufacturing plants running, and how Ireland would compare with Canada, Australia and the rest of Europe.
Industry
The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany
An in-depth salary and purchasing power analysis for Ireland's life sciences sector. Comparing gross €100k+ compensation packages against progressive marginal taxes, housing rent, and net disposable income in Dublin and Cork versus Basel, Munich, and Copenhagen.
Regulatory Affairs
Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform
The latest EFPIA Patients W.A.I.T. Indicator report reveals that Irish patients wait an average of 801 days to access newly approved medicines, prompting calls for an overhaul of the HSE and NCPE reimbursement processes and a dedicated mechanism for rare disease orphan drugs.
Regulatory Affairs
Beyond the Headline: Are Irish Pharma Workers Truly the Highest Paid in Europe?
Recent reports suggest Irish pharma workers are the highest paid in Europe, but a deeper dive reveals a more complex reality. We analyze compensation packages, tax regimes, and cost of living across Europe’s top pharmaceutical hubs.
Pharmaceutical
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Ireland’s Life Sciences Sector
An in-depth analysis of how US Most Favored Nation (MFN) drug pricing proposals and the Inflation Reduction Act (IRA) are forcing pharmaceutical companies to restructure indication sequencing, ex-US launches, and global supply chains.
Regulatory Affairs
How Most Favored Nation (MFN) Pricing Impacts Drug Development & Launch Planning
An expert analysis of the strategic shifts required in global drug development, indication sequencing, and launch timelines in response to proposed Most Favored Nation pricing and the Inflation Reduction Act.
Biotechnology
Rare Disease Bottlenecks vs. Encouraging Clinical Trial Growth in Ireland
Despite encouraging growth in clinical trial activity, patients in Ireland face an average wait of 801 days for access to rare disease medicines, prompting calls for urgent systemic reform.